Although this new generation of molecular therapy is promising, there are still several challenges to face, such as targeting delivery to specific tissues, avoiding off-target effects of miRNAs, reducing the toxicity of the drugs, and overcoming mutations and drug resistance.
Overcoming mutation-based resistance to antiandrogens with rational drug design.
In addition, targeting cellular systems responsible for PLP bioavailability (enzymes involved in PLP recycling and delivery; [ 65]) may represent a pharmacological approach to overcome mutation induced protein destabilization in PH1.
Therefore, targeting the cellular systems responsible for PLP bioavailability (enzymes involved in PLP recycling and delivery; [ 65]) may represent a pharmacological approach to overcome mutation induced protein destabilization in PH1.
These results provide strong biophysical evidence that allosteric interactions play a role in Abl kinase downregulation and that targeting sites outside the ATP binding site can provide an important pharmacological tool to overcome mutations that cause resistance to ATP-competitive inhibitors.
In addition, the incorporation of a phage-type RNA polymerase into plastid genome expression could have helped to overcome mutations in promoter regions, which are not transcribed (Maier et al. 2008).
Thank you for choosing to send your work entitled "Overcoming mutation-based resistance to antiandrogens with rational drug design" for consideration at eLife.
Targeting the Abl myristate binding site can provide an important pharmacological tool to suppress the rise of drug resistant mutations, and overcome existent mutations that are resistant to ATP-competitive inhibitors.
Newer genetic modifiers show an exciting potential for personalized medication, combining selection of patients with a common genetic mutation and a drug treatment that has been specifically designed to overcome that mutation, and will greatly enhance the therapeutic arsenal for PCD.
The uniqueness of these mutations suggested that an extreme modification of the RNAP molecule was required to overcome the mutation(s) that effectively blocked cell propagation on Trp.
